Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-19

FDA Approved: RIZATRIPTAN BENZOATE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for Rizatriptan Benzoate from Ascend Laboratories, LLC, for a generic rizatriptan benzoate product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rizatriptan Benzoate (rizatriptan benzoate)

Snippet

SUPPL AP for RIZATRIPTAN BENZOATE (RIZATRIPTAN BENZOATE)